Wilson MK - Search Results

1

Corrigendum to Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences: Am J Obstet Gynecol 225 (2021) 658.e1-658.e9/Article 658.

Madariaga A, Bhat G, Wilson MK, Li X, Cyriac S, Bowering V, Hunt W, Gutierrez D, Bonilla L, Kasherman L, McMullen M, Wang L, Ghai S, Dhani NC, Oza AM, Lheureux S. Madariaga A, et al. Among authors: wilson mk. Am J Obstet Gynecol. 2024 Apr 27:S0002-9378(24)00475-7. doi: 10.1016/j.ajog.2024.03.039. Online ahead of print. Am J Obstet Gynecol. 2024. PMID: 38679558 No abstract available.

2

Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences.

Madariaga A, Bhat G, Wilson MK, Li X, Cyriac S, Bowering V, Hunt W, Gutierrez D, Bonilla L, Kasherman L, McMullen M, Wang L, Ghai S, Dhani NC, Oza AM, Lheureux S. Madariaga A, et al. Among authors: wilson mk. Am J Obstet Gynecol. 2021 Dec;225(6):658.e1-658.e9. doi: 10.1016/j.ajog.2021.06.071. Epub 2021 Jun 23. Am J Obstet Gynecol. 2021. PMID: 34174204

3

Outcomes and endpoints in trials of cancer treatment: the past, present, and future.

Wilson MK, Karakasis K, Oza AM. Wilson MK, et al. Lancet Oncol. 2015 Jan;16(1):e32-42. doi: 10.1016/S1470-2045(14)70375-4. Epub 2014 Dec 29. Lancet Oncol. 2015. PMID: 25638553 Review.

4

Non-target progression--the fine line between objectivity and subjectivity.

Lheureux S, Wilson MK, O'Malley M, Sinaei M, Oza AM. Lheureux S, et al. Among authors: wilson mk. Eur J Cancer. 2014 Dec;50(18):3271-2. doi: 10.1016/j.ejca.2014.08.021. Epub 2014 Oct 18. Eur J Cancer. 2014. PMID: 25450948 No abstract available.

5

Discrepancies in drug approvals: A global dilemma.

Wilson MK, Karakasis K, Oza AM. Wilson MK, et al. Cancer. 2015 Sep 15;121(18):3360-1. doi: 10.1002/cncr.29484. Epub 2015 Jun 16. Cancer. 2015. PMID: 26079099 Free article. No abstract available.

6

Recent and current Phase II clinical trials in endometrial cancer: review of the state of art.

Lheureux S, Wilson M, Mackay HJ. Lheureux S, et al. Expert Opin Investig Drugs. 2014 Jun;23(6):773-92. doi: 10.1517/13543784.2014.907272. Epub 2014 Apr 9. Expert Opin Investig Drugs. 2014. PMID: 24717108 Review.

7

Estimation of expectedness: predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer.

Castonguay V, Wilson MK, Diaz-Padilla I, Wang L, Oza AM. Castonguay V, et al. Among authors: wilson mk. Cancer. 2015 Feb 1;121(3):413-22. doi: 10.1002/cncr.29030. Epub 2014 Oct 2. Cancer. 2015. PMID: 25278038 Free PMC article.

8

Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC).

Spreafico A, Oza AM, Clarke BA, Mackay HJ, Shaw P, Butler M, Dhani NC, Lheureux S, Wilson MK, Welch S, Zhang T, Yu C, Stockley T, Siu LL, Kamel-Reid S, Bedard PL. Spreafico A, et al. Among authors: wilson mk. Gynecol Oncol. 2017 Feb;144(2):250-255. doi: 10.1016/j.ygyno.2016.12.002. Epub 2017 Jan 3. Gynecol Oncol. 2017. PMID: 28062115

9

Resisting RECIST-Uniformity Versus Clinical Validity.

Wilson MK, Friedlander ML, Lheureux S, Small W Jr, Poveda A, Pujade-Lauraine E, Karakasis K, Bacon M, Bowering V, Chawla T, Oza AM. Wilson MK, et al. Int J Gynecol Cancer. 2017 Oct;27(8):1619-1627. doi: 10.1097/IGC.0000000000001062. Int J Gynecol Cancer. 2017. PMID: 28692635

10

A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve.

Wilson MK, Friedlander ML, Joly F, Oza AM. Wilson MK, et al. Oncologist. 2018 Feb;23(2):203-213. doi: 10.1634/theoncologist.2017-0297. Epub 2017 Nov 8. Oncologist. 2018. PMID: 29118265 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page